about
Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugsPharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant ProteinsRab26 modulates the cell surface transport of α2-adrenergic receptors from the GolgiRegulation of anterograde transport of adrenergic and angiotensin II receptors by Rab2 and Rab6 GTPasesPharmacological chaperoning: a primer on mechanism and pharmacologyAn ER complex of ODR-4 and ODR-8/Ufm1 specific protease 2 promotes GPCR maturation by a Ufm1-independent mechanismIdentification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cellsTrafficking and quality control of the gonadotropin releasing hormone receptor in health and diseaseDisturbances of sodium in critically ill adult neurologic patients: a clinical review.Postnatal expression of aquaporins in epithelial cells of the rat epididymis.Severe hydronephrosis in nephrogenic diabetes insipidusA single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors.Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms.Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus.Functional rescue of Kallmann syndrome-associated prokineticin receptor 2 (PKR2) mutants deficient in traffickingAdenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.A single lys residue on the first intracellular loop modulates the endoplasmic reticulum export and cell-surface expression of α2A-adrenergic receptorAnalysis of a novel AVPR2 mutation in a family with nephrogenic diabetes insipidus.Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine.Alpha2B-adrenergic receptor interaction with tubulin controls its transport from the endoplasmic reticulum to the cell surface.Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonistChloride channels in the kidney: lessons learned from knockout animals.Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.Misrouted cell surface receptors as a novel disease aetiology and potential therapeutic target: the case of hypogonadotropic hypogonadism due to gonadotropin-releasing hormone resistance.X-Linked Recessive form of Nephrogenic Diabetes Insipidus in a 7-Year-Old Boy.Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptorsNeuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.Assay strategies for identification of therapeutic leads that target protein traffickingRegulation of G protein-coupled receptor export trafficking.Genetically modified mouse models for pharmacogenomic research.Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.Rescue of misrouted GnRHR mutants reveals its constitutive activityReceptor antagonism/agonism can be uncoupled from pharmacoperone activity.Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD.Vasopressin regulates renal calcium excretion in humans.Protein quality control: the who's who, the where's and therapeutic escapes.Aquaporins: a promising target for drug development.GGA3 Interacts with a G Protein-Coupled Receptor and Modulates Its Cell Surface Export.Chemical and pharmacological chaperones as new therapeutic agents.
P2860
Q21089948-562482CE-9796-4CE5-ABE2-38405825DAFFQ21131288-C99687D3-83DF-424E-9CA9-1142A65CF1EBQ24302003-A1E21CD8-6B04-4185-91DF-16C6DA565D14Q24680800-6E07F0DA-BAF9-40FC-9446-2BF8FC2ED095Q27001695-A524A2C2-4367-4734-B415-EC5ABEE65AA1Q27317342-E76DD5DA-18C5-4390-A78C-47C6058CB80CQ28566309-AE4DB250-7848-4B51-B593-4BFE7DF17000Q28755163-1721713A-7C79-4E81-981B-C552B1F354E7Q30499500-14BD2348-9DA4-4B4A-AA95-F981952CD1E5Q30800224-5CA7A5A0-C4A3-445B-8530-39924661BB29Q33571552-E462FA02-4A4D-4FE8-8C40-7CE9D77564B0Q33780776-EB00CB73-1B70-409A-8F8B-B780C7F800C5Q33862041-CD6FBE26-833D-4E30-B21D-A5103F2657E7Q33898137-C3F0DCA9-20C3-4ED9-A2B6-775F9BA11A65Q34020528-0367FE1A-854D-4BAB-8253-1D639727DCCBQ34075966-BC29CF13-EBF4-4BA7-8025-E06E611023A0Q34457128-E4DBEFC6-FDAD-4003-ACA5-CBC83071CABCQ34506992-DA30AD08-5406-4960-A860-76C77E97252DQ34625582-3FB3255B-4960-4473-80D9-1C50E27AF25FQ34667495-6D7BC92D-31D2-4ED4-8764-070681FA4AC1Q34800068-D5B032A9-01CD-44C0-B1A2-5EDA3D227941Q34881143-BDE83314-4357-477D-831D-955AF21140E1Q34993939-E3D3BBDF-F7E8-490F-B6BE-7E92450538DDQ35080543-D4522559-9840-46AE-866E-1B05FEF763BDQ35095132-9B9A9DE2-A6B9-488A-8D92-987F77518338Q35549663-8C044DDC-8ACE-4D2E-8255-57E319B97273Q35606973-AC40BEF1-58DF-4B83-9578-8F2CB5D4A76EQ35617513-9027BBDD-C065-441A-9EF2-98108BD6270FQ35661403-1B937649-A43C-4A2C-8C86-C5DFCCD9E3BCQ35827970-09355D99-9C29-4FE4-94A6-3E53A38A116FQ35889610-D24270AA-F6E9-41B6-BA3B-6A5AB8EC8F33Q35915771-C0E36F15-315F-4E8D-AF3A-0685F6E6A10BQ36065485-384360F9-3A6E-4B8C-AAF4-22746C2E750FQ36070628-6D99C3A6-B6F5-4127-A89B-AB2BA0E10A2AQ36280354-BEBEF20D-FC3B-4F52-A15D-CF924998EEF2Q36357468-469AD497-7065-4A14-89BE-BDC85BF86C46Q36432134-6ABEBFAE-0B2B-4F9F-93B4-75F0405BA111Q36653672-46226A93-A98C-4E39-A28C-77F92D116EBDQ36709235-AF28F398-1978-436F-96CB-96A76EF109B4Q36863386-19A47D1C-E8C7-4618-9A2F-308BA5E510C2
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nephrogenic diabetes insipidus.
@ast
Nephrogenic diabetes insipidus.
@en
type
label
Nephrogenic diabetes insipidus.
@ast
Nephrogenic diabetes insipidus.
@en
prefLabel
Nephrogenic diabetes insipidus.
@ast
Nephrogenic diabetes insipidus.
@en
P1476
Nephrogenic diabetes insipidus.
@en
P2093
P304
P356
10.1146/ANNUREV.PHYSIOL.63.1.607
P577
2001-01-01T00:00:00Z